Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44351 clinical trials with a EudraCT protocol, of which 7378 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,351)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,351 result(s) found. Displaying page 168 of 2,218.

EudraCT Number: 2007-003835-22

Sponsor Protocol Number: 2007.478

Start Date*: 2007-11-20

Sponsor Name:Hospices Civils de Lyon

Full Title: Evaluation d’une protéine ostéo-inductrice (rhBMP-2) dans le traitement de la pseudarthrose congénitale du tibia de l’enfant

Medical condition: pseudarthrose congénitale du tibia de l’enfant

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10061573	Congenital pseudarthrosis	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-004524-21	Sponsor Protocol Number: 9000	Start Date*: 2008-02-12
Sponsor Name:Medicinsk gastroenterologisk afdeling, Aalborg Sygehus S
Full Title: Undersøgelse af opioiders analgetiske og anti-hyperalgesiske effekt på eksperimentelle smertemodeller i huden, musklerne og knoglerne
Medical condition: Eksperimentelle smertemodeller
Disease:
Population Age: Adults		Gender: Male
Trial protocol: DK (Completed)
Trial results: (No results available)

EudraCT Number: 2004-000502-40	Sponsor Protocol Number: RHM CAN0380	Start Date*: 2005-05-13
Sponsor Name:Southampton University Hospitals Trust
Full Title: A thematic analysis of semi-structured interviews using a phenomenological approach into palliative care patients experiences of change in "fatigue" following treatment with methylphenidate – an ex...
Medical condition: Patients with cancer in palliative stage of their illness. Suffering from fatigue with or without decreased concentration, depression or drowsiness, who feel their fatigue is severe enough to decre...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA)
Trial results: (No results available)

EudraCT Number: 2010-021002-38

Sponsor Protocol Number: ATADAR

Start Date*: 2010-11-10

Sponsor Name:Fundació Clínic per a la Recerca Biomèdica

Full Title: Estudio sobre los efectos metabólicos de atazanavir/ritonavir versus darunavir/ritonavir en combinación con tenofovir/emtricitabina en pacientes infectados por el VIH-1 sin tratamiento previo: ensa...

Medical condition: Tratamiento para pacientes infectados por el VIH-1 sin tratamiento previo

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13		10020160	Enfermedad por VIH	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: (No results available)

EudraCT Number: 2010-021003-24

Sponsor Protocol Number: 20100754

Start Date*: 2011-07-28

Sponsor Name:Amgen Inc

Full Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dys...

Medical condition: Acute heart failure

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004849	10000803	Acute heart failure	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GR (Completed) GB (Completed) LT (Completed) FI (Prematurely Ended) SK (Completed) CZ (Completed) HU (Completed) PL (Completed) BE (Completed) IT (Completed) NL (Completed)

Trial results: View results

EudraCT Number: 2004-002302-30

Sponsor Protocol Number: 83/2004/U/Sper

Start Date*: 2004-07-20

Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Full Title: FMZ Fludarabine, Mitoxantrone, Zevalin regimen a phase II study as front-line treatment in indolent non-follicular non-Hodgkins lymphoma patients

Medical condition: Confirmed histologic diagnosis according to the REAL classification of B-cell indolent lymphoma including small lymphocytic, immunocytoma, and marginal zone lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	6.1		10003900		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000140-25

Sponsor Protocol Number: 2003141

Start Date*: 2004-09-08

Sponsor Name:Procter & Gamble Pharmaceuticals

Full Title: A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of 2 mg/kg Bolus Plus 24-hour 0.05 mg/kg/hr Infusion Pexelizumab in Patients Undergoing Coronary Artery Bypass Graf...

Medical condition: Prevention of systemic inflammatory response predominantly triggered by the interaction between the patient’s blood and the pump’s artificial surfaces in patients undergoing coronary artery bypass ...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10006894		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000311-26

Sponsor Protocol Number: 0431-019

Start Date*: 2004-07-21

Sponsor Name:Merck & Co., Inc.

Full Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus who Have Inadequate Glycemic Control on Piogli...

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10045242		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) LT (Completed) AT (Completed) IT (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-000344-24

Sponsor Protocol Number: D4320C00006

Start Date*: 2004-10-29

Sponsor Name:AstraZeneca AB

Full Title: A phase II, randomised, double-blind, parallel-group, placebo-controlled, multi-centre study to assess the efficacy and safety of once-daily orally administered ZD4054 15 mg and 10 mg doses in pain...

Medical condition: Hormone-refractory prostate cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	6.1		10062904		LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: FI (Completed) SE (Completed) GB (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-001128-19	Sponsor Protocol Number: CV185-010	Start Date*: 2004-11-02
Sponsor Name:Bristol-Myers Squibb International Corporation
Full Title: A Phase 2 Randomized, Double Blinded (BMS-562247 and enoxaparin), Active-Controlled (enoxaparin and warfarin), Parallel-Arm, Dose Response Study of the Oral Factor Xa Inhibitor BMS-562247 in Subjec...
Medical condition: Prevention of asymptomatic and symptomatic deep vein thrombosis (DVT) and non-fatal pulmonary embolism (PE) in subjects undergoing knee replacement surgery.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: View results

EudraCT Number: 2004-000766-12	Sponsor Protocol Number: SCO/BIA-2093-301	Start Date*: 2005-03-21
Sponsor Name:BIAL Portela & Companhia, S.A.
Full Title: Efficacy and safety of BIA 2-093 as adjunctive therapy for refractory partial seizures in a double-blind, randomised, placebo-controlled, parallel-group, multicentre clinical trial
Medical condition: About 40% of the patients suffering from epilepsy are not satisfactorily controlled and 25% suffer from significant adverse events. This lack of seizure control means that combination therapy is of...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2004-000771-34

Sponsor Protocol Number: IC010RUP/3/04

Start Date*: 2004-10-28

Sponsor Name:J. Uriach y Compañía, S.A.

Full Title: A 6-week multicentre, double-blind, randomised, placebo-controlled, parallel-group study to assess the efficacy and safety of rupatadine 10 and 20 mg in the treatment of Chronic Idiopathic Urticar...

Medical condition: Chronic Idiopathic Urticaria

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7		10021247		0

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000784-97

Sponsor Protocol Number: SB-275833/032

Start Date*: 2004-02-16

Sponsor Name:GlaxoSmithKline Research & Development Ltd

Full Title: A Randomized, Double-blind, Double-Dummy, Multicenter, Non-inferiority Phase III Study to Assess the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily, versus Oral Cephalexi...

Medical condition: Secondarily-Infected Dermatoses

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10012470		PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-000798-71	Sponsor Protocol Number: 1	Start Date*: 2004-08-11
Sponsor Name:Imperial College London
Full Title: Efficacy of Levetiracetam in Pendular Nystagmus: A Randomized, Double-blind, Placebo-controlled trial with crossover
Medical condition: Pendular Nystagmus from various etiology
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: View results

EudraCT Number: 2004-000799-15	Sponsor Protocol Number: 04-04074	Start Date*: 2004-09-09
Sponsor Name:Aker University Hospital
Full Title: DOES BENFOTIAMINE SUPPLEMENTATION REDUCE SERUM LEVELS OF ADVANCED GLYCATION END PRODUCTS AND BIOCHEMICAL MARKERS OF VASCULAR DYSFUNCTION IN TYPE 1 DIABETES?
Medical condition: Type 1 diabetes
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: NO (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-000803-17	Sponsor Protocol Number: SAVE	Start Date*: 2006-01-06
Sponsor Name:The SAVE trial group
Full Title: Prospective, controlled clinical study on the effect of 120 mg depot-methyl-prednisolone compared to placebo on the course of recent onset arthritis
Medical condition: Early undifferentiated arthritis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: LT (Completed)
Trial results: (No results available)

EudraCT Number: 2004-000816-24

Sponsor Protocol Number: FRAN-03-001

Start Date*: 2004-10-28

Sponsor Name:Abbott France

Full Title: A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen versus Lopinavir/Ritonavir in Combination with Lamivudine/Zidovudine in Antir...

Medical condition: HIV-1 Infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10020192		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-000914-37	Sponsor Protocol Number: NEU 1X	Start Date*: 2004-08-12
Sponsor Name:Neurim Pharmaceuticals (1991) Ltd
Full Title: A DOUBLE-BLIND, PARALLEL GROUP, RANDOMISED, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF CIRCADIN® 2MG IN THE IMPROVEMENT OF SLEEP QUALITY IN PATIENTS WITH INSOMNIA AGED 55-80 YEARS.
Medical condition: Primary Insomnia in adults over 55 years
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2004-000915-25

Sponsor Protocol Number: D1447C00144

Start Date*: 2005-04-22

Sponsor Name:AstraZeneca R&D Sodertalje

Full Title: Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 weeks Maintenanc...

Medical condition: Bipolar I Disorder

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10004939	Bipolar I disorder	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-000929-30

Sponsor Protocol Number: MHE100185

Start Date*: 2004-07-08

Sponsor Name:GLAXO SMITHKLINE

Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase III Study to Evaluate Corticosteroid-reduction and -sparing Effects of Mepolizumab 750 mg Intravenous in Subjects w...

Medical condition: HES

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	6.1		10048643		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Jul 22 08:49:41 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA